Sensitivity, specificity, positive-predictive value, and negative-predictive value analyses for 1-year NRM
| . | Sensitivity . | Specificity . | PPV . | NPV . | |
|---|---|---|---|---|---|
| Test cohort | 0.70 | 0.74 | 0.55 | 0.85 | |
| Validation cohort 1 | 0.80 | 0.76 | 0.58 | 0.91 | |
| Validation cohort 2 | 0.63 | 0.93 | 0.58 | 0.91 | |
| Minnesota risk | Early treatment response | ||||
| Standard | Response | 0.50 | 0.86 | 0.29 | 0.94 |
| Standard | Nonresponse | 0.55 | 0.84 | 0.46 | 0.88 |
| High* | Response | NA | NA | NA | NA |
| High | Nonresponse | 0.94 | 0.54 | 0.84 | 0.78 |
| . | Sensitivity . | Specificity . | PPV . | NPV . | |
|---|---|---|---|---|---|
| Test cohort | 0.70 | 0.74 | 0.55 | 0.85 | |
| Validation cohort 1 | 0.80 | 0.76 | 0.58 | 0.91 | |
| Validation cohort 2 | 0.63 | 0.93 | 0.58 | 0.91 | |
| Minnesota risk | Early treatment response | ||||
| Standard | Response | 0.50 | 0.86 | 0.29 | 0.94 |
| Standard | Nonresponse | 0.55 | 0.84 | 0.46 | 0.88 |
| High* | Response | NA | NA | NA | NA |
| High | Nonresponse | 0.94 | 0.54 | 0.84 | 0.78 |
NPV, negative-predictive value; PPV, positive-predictive value.
Too few patients with Minnesota high risk and early treatment response to calculate sensitivity, specificity, positive-predictive value, and negative-predictive value